288 related articles for article (PubMed ID: 37521034)
1. A Bibliometric Analysis of Mesenchymal Stem Cell-Derived Exosomes in Acute Lung Injury/Acute Respiratory Distress Syndrome from 2013 to 2022.
Zhou W; Hu S; Wu Y; Xu H; Zhu L; Deng H; Wang S; Chen Y; Zhou H; Lv X; Li Q; Yang H
Drug Des Devel Ther; 2023; 17():2165-2181. PubMed ID: 37521034
[TBL] [Abstract][Full Text] [Related]
2. A bibliometric analysis of NLRP3 inflammasome in acute lung injury/acute respiratory distress syndrome from 2010 to 2021.
Xiao Z; Hu S; Xu W; Wang S; Mo W; Deng H; Wei J; Yang H; Zhou W; Li Q; Zhou H; Lv X
Front Immunol; 2022; 13():1053658. PubMed ID: 36618363
[TBL] [Abstract][Full Text] [Related]
3. Global Research Trends and Hotspots on Mitochondria in Acute Lung Injury from 2012-2021: A Bibliometric Analysis.
Hu S; Zhou W; Wang S; Xiao Z; Li Q; Zhou H; Liu M; Deng H; Wei J; Zhu W; Yang H; Lv X
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612909
[TBL] [Abstract][Full Text] [Related]
4. A bibliometric analysis of programmed cell death in acute lung injury/acute respiratory distress syndrome from 2000 to 2022.
Huang E; Gao L; Yu R; Xu K; Wang L
Heliyon; 2023 Sep; 9(9):e19759. PubMed ID: 37809536
[TBL] [Abstract][Full Text] [Related]
5. Global Trends in Research of Macrophages Associated With Acute Lung Injury Over Past 10 Years: A Bibliometric Analysis.
Wang S; Zhou H; Zheng L; Zhu W; Zhu L; Feng D; Wei J; Chen G; Jin X; Yang H; Shi X; Lv X
Front Immunol; 2021; 12():669539. PubMed ID: 34093568
[TBL] [Abstract][Full Text] [Related]
6. Publication trends of research on acute lung injury and acute respiration distress syndrome during 2009-2019: a 10-year bibliometric analysis.
Wang C; Wang X; Long X; Xia D; Ben D; Wang Y
Am J Transl Res; 2020; 12(10):6366-6380. PubMed ID: 33194036
[TBL] [Abstract][Full Text] [Related]
7. Global research progress of endothelial cells and ALI/ARDS: a bibliometric analysis.
Zhou T; Long K; Chen J; Zhi L; Zhou X; Gao P
Front Physiol; 2024; 15():1326392. PubMed ID: 38774649
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.
Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616
[TBL] [Abstract][Full Text] [Related]
9. A bibliometric analysis of acute respiratory distress syndrome (ARDS) research from 2010 to 2019.
Zhang X; Wang C; Zhao H
Ann Palliat Med; 2021 Apr; 10(4):3750-3762. PubMed ID: 33752427
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials.
Wang F; Fang B; Qiang X; Shao J; Zhou L
Respir Res; 2020 Nov; 21(1):307. PubMed ID: 33218340
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in mesenchymal stem cell-based therapy for acute lung injury.
Liang J; Dai W; Xue S; Wu F; Cui E; Pan R
Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges.
Wang Z; Yu T; Hou Y; Zhou W; Ding Y; Nie H
Curr Pharm Des; 2022; 28(27):2234-2240. PubMed ID: 35796453
[TBL] [Abstract][Full Text] [Related]
13. Trends in research on acute lung injury/acute respiratory distress syndrome associated with viral pneumonia from 1992 to 2022: a 31-year bibliometric analysis.
Zhang L; Mei S; Zhu B; Zhao Z
Front Med (Lausanne); 2023; 10():1158519. PubMed ID: 37359015
[TBL] [Abstract][Full Text] [Related]
14. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
[TBL] [Abstract][Full Text] [Related]
15. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Current Research on Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Bibliometric Analysis From 2009 to 2021.
Zhang X; Lu Y; Wu S; Zhang S; Li S; Tan J
Front Bioeng Biotechnol; 2022; 10():910812. PubMed ID: 35814000
[No Abstract] [Full Text] [Related]
17. Bibliometric analysis of acute respiratory distress syndrome (ARDS) studies published between 1980 and 2020.
Yildirim F; Gulhan PY; Karaman I; Kurutkan MN
Adv Clin Exp Med; 2022 Jul; 31(7):807-813. PubMed ID: 35699587
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis.
Fengyun W; LiXin Z; Xinhua Q; Bin F
Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559
[TBL] [Abstract][Full Text] [Related]
19. Advances in the use of exosomes for the treatment of ALI/ARDS.
Liu C; Xiao K; Xie L
Front Immunol; 2022; 13():971189. PubMed ID: 36016948
[TBL] [Abstract][Full Text] [Related]
20. Bibliometric analysis of global research trends on pyroptosis in lung disease.
Mo W; Li Q; Zhou H; Shi X; Yang H; Xiao Z; Wei J; Lv X
Front Immunol; 2022; 13():978552. PubMed ID: 36177039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
